BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 30591389)

  • 21. Effect of levofloxacin, erythromycin or rifampicin pretreatment on growth of Legionella pneumophila in human monocytes.
    Smith RP; Baltch AL; Franke M; Hioe W; Ritz W; Michelsen P
    J Antimicrob Chemother; 1997 Nov; 40(5):673-8. PubMed ID: 9421315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotic susceptibility of Legionella strains isolated from public water sources in Macau and Guangzhou.
    Xiong L; Yan H; Shi L; Mo Z
    J Water Health; 2016 Dec; 14(6):1041-1046. PubMed ID: 27959883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibiotic Susceptibility of Environmental
    Cocuzza CE; Martinelli M; Perdoni F; Giubbi C; Vinetti MEA; Calaresu E; Frugoni S; Scaturro M; Ricci ML; Musumeci R
    Int J Environ Res Public Health; 2021 Sep; 18(17):. PubMed ID: 34501942
    [No Abstract]   [Full Text] [Related]  

  • 24. Correlation of MIC value and disk inhibition zone diameters in clinical Legionella pneumophila serogroup 1 isolates.
    Bruin JP; Diederen BM; Ijzerman EP; Den Boer JW; Mouton JW
    Diagn Microbiol Infect Dis; 2013 Jul; 76(3):339-42. PubMed ID: 23583350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and Europe.
    Critchley IA; Jones ME; Heinze PD; Hubbard D; Engler HD; Evangelista AT; Thornsberry C; Karlowsky JA; Sahm DF
    Clin Microbiol Infect; 2002 Apr; 8(4):214-21. PubMed ID: 12047413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotic Resistance of
    Pappa O; Chochlakis D; Sandalakis V; Dioli C; Psaroulaki A; Mavridou A
    Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32796666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Susceptibility of Legionella pneumophila to antimicrobial agents and the presence of the efflux pump LpeAB.
    Natås OB; Brekken AL; Bernhoff E; Hetland MAK; Löhr IH; Lindemann PC
    J Antimicrob Chemother; 2019 Jun; 74(6):1545-1550. PubMed ID: 30815687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phylogenetic analysis of environmental Legionella pneumophila isolates from an endemic area (Alcoy, Spain).
    Sánchez-Busó L; Olmos MP; Camaró ML; Adrián F; Calafat JM; González-Candelas F
    Infect Genet Evol; 2015 Mar; 30():45-54. PubMed ID: 25511251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic Resistance and Azithromycin Resistance Mechanism of Legionella pneumophila Serogroup 1 in China.
    Jia X; Ren H; Nie X; Li Y; Li J; Qin T
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31405864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial agent susceptibilities of Legionella pneumophila MLVA-8 genotypes.
    Sharaby Y; Nitzan O; Brettar I; Höfle MG; Peretz A; Halpern M
    Sci Rep; 2019 Apr; 9(1):6138. PubMed ID: 30992549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial susceptibility profiles and tentative epidemiological cutoff values of
    Yang JL; Sun H; Zhou X; Yang M; Zhan XY
    Front Microbiol; 2022; 13():924709. PubMed ID: 36312931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracellular activity of ABT-773 and other antimicrobial agents against Legionella pneumophila.
    Jung R; Danziger LH; Pendland SL
    J Antimicrob Chemother; 2002 May; 49(5):857-61. PubMed ID: 12003984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Activity of macrolides and fluoroquinolones against intracellular Legionella pneumophila].
    Yu LL; Hu BJ; Huang SL; Zhou ZY; Tao LL
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jun; 34(6):409-12. PubMed ID: 21781510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular epidemiology of Legionella pneumophila serogroup 1 isolates following long-term chlorine dioxide treatment in a university hospital water system.
    Casini B; Valentini P; Baggiani A; Torracca F; Frateschi S; Nelli LC; Privitera G
    J Hosp Infect; 2008 Jun; 69(2):141-7. PubMed ID: 18439718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activities of antimicrobial peptides and ceragenins against Legionella pneumophila.
    Birteksoz-Tan AS; Zeybek Z; Hacioglu M; Savage PB; Bozkurt-Guzel C
    J Antibiot (Tokyo); 2019 May; 72(5):291-297. PubMed ID: 30755738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of Legionella species isolated from shower water in public bath facilities in Toyama Prefecture, Japan.
    Kanatani JI; Isobe J; Norimoto S; Kimata K; Mitsui C; Amemura-Maekawa J; Kura F; Sata T; Watahiki M
    J Infect Chemother; 2017 May; 23(5):265-270. PubMed ID: 28188095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Chlorine and Chloramine on the Detection and Quantification of Legionella pneumophila and
    Donohue MJ; Vesper S; Mistry J; Donohue JM
    Appl Environ Microbiol; 2019 Dec; 85(24):. PubMed ID: 31604766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative susceptibility of Legionella pneumophila and Legionella longbeachae to 12 antimicrobial agents.
    Nimmo GR; Bull JZ
    J Antimicrob Chemother; 1995 Jul; 36(1):219-23. PubMed ID: 8537269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The hazards of hospitals and selected public buildings of Legionella pneumophila].
    Sikora A; Kozioł-Montewka M; Wójtowicz-Bobin M; Gładysz I; Dobosz P
    Pol Merkur Lekarski; 2013 Nov; 35(209):263-7. PubMed ID: 24575645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells.
    Stout JE; Arnold B; Yu VL
    Diagn Microbiol Infect Dis; 1998 Jan; 30(1):37-43. PubMed ID: 9488830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.